Skip to content

Glycemic and Insulinemic Response of Pasta Products in Comparison to Asian Foods

Glycemic and Insulinemic Response of Pasta Products in Comparison to Asian

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03646812
Enrollment
32
Registered
2018-08-24
Start date
2018-08-10
Completion date
2020-06-01
Last updated
2023-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

The aim of the study is to determine the glycaemic and insulinaemic index of pasta products and local foods. It is hypothesized that different pasta cuts and wholegrain composition of pasta and local foods have different GI depending on the nature of the carbohydrate content and the food structure within each food.

Detailed description

There will be a total of 9 test sessions and each session will last up to 3.5 hours. The order of sessions will be determined with an online randomizer. At each test session, the following procedures will be performed: two finger-prick blood samples, five minutes apart to measure baseline blood glucose and insulin concentrations Subject will be served the test food and to consume within15 minutes Following the test meal, blood samples will be collected at the following time points: 15, 30, 45, 60, 90, 120, 150 and 180min for glucose measurements and insulin measurements will be collected at 30, 60, 90, 120, 150 and 180min.

Interventions

Glucose contains 50g of available carbohydrates

Glucose contains 50g of available carbohydrates

Glucose contains 50g of available carbohydrates

OTHERSemolina Penne

Semolina Penne contains 50g of available carbohydrates

OTHERWholegrain Penne

Wholegrain Penne contains 50g of available carbohydrates

OTHERSemolina Spaghetti

Semolina Spaghetti contains 50g of available carbohydrates

OTHERWholegrain Spaghetti

Wholegrain Spaghetti contains 50g of available carbohydrates

Jasmine Rice contains 50g of available carbohydrates

OTHERAsian Noodles

Asian Noodles contains 50g of available carbohydrates

Sponsors

Barilla Singapore Pte Ltd
CollaboratorUNKNOWN
Singapore Institute of Food and Biotechnology Innovation
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy Asian - Indian and Chinese ethnicity * Age between 21-40 years * Body mass index between 18.5 to 25 kg/m2 * Normal blood pressure (\<140/90 mmHg) * Fasting blood glucose \< 6 mmol/L

Exclusion criteria

* Is a current smoker * Is currently pregnant * Have any metabolic diseases (such as diabetes, hypertension etc) * Have known glucose-6-phosphate dehydrogenase deficiency (G6PD deficiency) * Have medical conditions and/or taking medications known to affect glycemia(glucocorticoids, thyroid hormones, thiazide diuretics) * Have any major organ dysfunction (e.g. cardiovascular, respiratory, hepatic, renal, gastrointestinal) that may influence taste, olfaction, appetite, digestion, metabolism, absorption or elimination of test foods, nutraceutical or drug * Have any severe food allergy (e.g. anaphylaxis to peanuts) * Have any known allergies to any food components of the study protocol * Have active Tuberculosis (TB) or currently receiving treatment for TB * Have any known Chronic infection or known to suffer from or have previously suffered from or is a carrier of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV) * Is a study team member or an immediate family of any study team member. Immediate family member is defined as a spouse, parent, child, or sibling, whether biological or legally adopted. * enrolled in a concurrent research study judged not to be scientifically or medically compatible with the study. * Have partake in sports at the competitive and/or endurance levels * Have intentionally restrict food intake

Design outcomes

Primary

MeasureTime frameDescription
Glucoseup to 180 minutesBlood will be collected and measured using hemocue analyzer.
Insulinup to 180 minutesBlood will be collected and measured using COBAS analyzer.

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026